drugset / Trial / NCT03039049

GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT

NCT03039049

Phase 3 Completed 328 enrolled Centre Hospitalier Universitaire Ibn Rochd
RandomizedParallel-groupDouble-blindTreatment

Summary

Purpose:The aim of this project is to prospectively determine whether a single dose of GnRH-agonist administered at the time of implantation increases or not the reproductive outcome in patients undergoing in vitro fertilization ( IVF)/ intracytoplasmatic sperm injection(ICSI) triggered by a GnRH-agonist followed by a small bolus of human chorionic gonadotropin (hCG 1500 IU) the day of oocyte retrieval.

Timeline

Start
2014-03
Primary completion
2017-03
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Triptorelin Other / unclassified 0.1 mg Subcutaneous

Indications